Phosphospecific chemokine receptor antibodies
US7892767B2 · kind B2 · utility
0Cited by
6References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 30, 2006 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Sep 10, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides chemokine receptor antibodies that selectively bind to an activated form of the receptor but not to a non activated form of the receptor. In particular, the current invention provides phosphospecific chemokine receptor antibodies. The antibodies can be used in several diagnostic, screening and purification methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.